Taking vyvanse / lisdexamfetamine out of New Zealand
Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from New Zealand requires prescription documentation and stays within personal-use limits.
Details
Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the Misuse of Drugs Act 1975; Customs and Excise Act 2018 framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from New Zealand; above these limits a Medsafe personal export authorisation is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.
Quantity limits
Personal-use quantity (typically ≤90 days' supply)
Documentation required
- Prescription with quantity dispensed
- Doctor's letter stating medical need
- Medsafe personal export authorisation (if above personal-use)
The other direction
Bringing vyvanse / lisdexamfetamine into New Zealand(restricted)